Business Wire

United Language Group Completes 2nd Acquisition: Acquires KJ International and Closes Merrill Brink Transaction


United Language Group (ULG) today announced the completion of its acquisition of Merrill Brink International, formerly a subsidiary of Merrill Corporation. Simultaneously, ULG acquired its 2nd company, KJ International Resources (KJI), a Minneapolis-based language-service provider specializing in the life sciences sector.

ULG was formed in 2015 by industry veterans Jeff Brink, Hans Fenstermacher, and Greg Brink, later joined by veteran CFO Karrie Willis, as a platform to assemble a family of complementary companies, with a goal of becoming one of the largest language-service providers in the world.

“We are delighted to launch our strategy with Merrill Brink, then immediately strengthen our life sciences practice with KJ International,” said Jeff Brink, CEO of ULG. “Both companies have developed strong brands and customer loyalty, and share similar corporate cultures. Additionally, both organizations will benefit from cross-pollination of complementary technologies, skillsets and an expanded global footprint. We believe KJ International is a perfect fit, underscoring our commitment to the life sciences sector.”

“We are thrilled to be joining forces with ULG. This opportunity will benefit our clients as we expand our current translation and localization offerings, and further advance our skills and expertise within highly regulated industries,” said Kristen Giovanis, co-founder and CEO of KJI. With its second acquisition, ULG is already at approximately $50 million in annual revenues, immediately ranking it in the top 25 language-service companies worldwide, according to industry analyst Common Sense Advisory.

ULG is backed by equity investment firm Northern Pacific Group (NPG), with mezzanine capital from Yukon Partners (Yukon) and senior credit from Bell Capital. “We’re excited about this investment in the language business and we see tremendous opportunities for growth, both organically and through further acquisitions. We expect to be very active in this highly-fragmented $40 billion industry,” said Peter Offenhauser, Partner of NPG.

Mike Hall, Managing Partner of Yukon, added, “We are excited to partner with NPG and ULG management to support the Company’s growth strategy. We are confident that with NPG’s leadership, alongside management’s strong operational expertise and industry experience, the ULG platform is well positioned for future growth.”

About United Language Group

United Language Group is a global organization headquartered in Minneapolis with offices in New York, Hong Kong, Galway (Ireland), and London. ULG is dedicated to building and managing a portfolio of high-performing and complementary language service providers. United Language Group adds value and leverages synergies for the collective benefit of its companies and customers. For more information, please visit

About Northern Pacific Group

Northern Pacific Group is a Minnesota-based growth equity investment firm focused on acquiring and investing in growing companies in the Midwest. Northern Pacific Group seeks to partner with ownership groups and management teams in order to add value beyond just providing capital. For more information, please visit

About KJ International Resources

KJ International Resources is a leading provider of translation and localization services in a wide range of medical, technical and other highly regulated fields. KJI is committed to excellent customer service and high quality language services that support the global requirements of our international clients. For more information, please visit

About Yukon Partners

Yukon Partners is an independent and unaffiliated mezzanine firm primarily serving middle market private equity sponsored business transactions with a typical investment range of $10 to $40 million in the U.S. and Canada. The transactions in which Yukon invests include buyouts, growth and platform strategies, recapitalizations, mergers/acquisitions, and public-to-private buyouts. Yukon Partners is based in Minneapolis, Minnesota. For more information, please visit

Contact information

United Language Group
Jeff Brink, +1 612-916-6060
Merrill Brink International
Vanessa Lontoc, +1 212-229-6532
Marketing Manager

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on